Zicam Sales Up, Matrixx Cuts Loss With Legal Expenses Down More Than Half
This article was originally published in The Tan Sheet
Executive Summary
High sales of Matrixx Initiatives' Zicam line in an out-of-season quarter helped the OTC manufacturer increase cold and cough product sales, the firm said
You may also be interested in...
Zinc Gluconate Sprays Challenged In Lawsuits; Matrixx Defends Zicam Safety
The safety of zinc gluconate sprays has been called into question by a recent spate of lawsuits alleging that the products cause users to lose their sense of smell
FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns
The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products
FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns
The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products